The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
CONCLUSIONS: Our data support the use of week 3 and EOT US for prediction of pCR in response-guided NAT and in planning of breast-conserving surgery. Change in tumor diameter on US as a continuous variable could be a valuable alternative to categorical RECIST 1.1 criteria.PMID:34166854 | DOI:10.1016/j.breast.2021.06.001
Source: Breast - Category: Cancer & Oncology Authors: Monika Graeser Nadia Harbeck Oleg Gluz Rachel W ürstlein Christine Zu Eulenburg Claudia Schumacher Eva-Maria Grischke Helmut Forstbauer Moritz Dimpfl Michael Braun Matthias Christgen Hans Heinrich Kreipe Jochem Potenberg Raquel von Schumann Bahriye Aktas Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | HER2 | Neoadjuvant Therapy | Ultrasound